Does ProShare Advisors own IOVA stock?

Yes. As of its Q3 2026 13F, ProShare Advisors holds 65,672 shares of IOVA (Iovance Biotherapeutics), worth $973,259.

How many shares of IOVA does ProShare Advisors own?

As of its Q3 2026 13F, ProShare Advisors holds 65,672 shares of IOVA (Iovance Biotherapeutics).

What is ProShare Advisors' IOVA position worth?

As of its Q3 2026 13F, ProShare Advisors' IOVA position is worth $973,259.

Is ProShare Advisors buying or selling IOVA?

In Q3 2026, ProShare Advisors reduced its IOVA position by 1,077 shares (-1.6%).

When did ProShare Advisors first buy IOVA?

ProShare Advisors already held IOVA in its Q4 2018 13F, the earliest on record, and has listed it in 32 quarterly 13F filings.

Back to

ProShare Advisors LLC

IOVA

32 quarters

Position history for ProShare Advisors LLC's holdings in Iovance Biotherapeutics, Inc.

Current Value

$973,259

Current Shares

65,672

Total Value Change

+$505,259

Total Shares Change

+12,798

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q3 Latest	Decreased	65,672	-1.6%	$973,259	0.0%	$14.82	0
2026-Q2	Decreased	66,749	-0.9%	$277,677	0.0%	$4.16	0
2026-Q1	Decreased	67,326	-8.7%	$236,314	0.0%	$3.51	0
2025-Q4	Increased	73,733	+28.1%	$201,291	0.0%	$2.73	28
2025-Q3	Decreased	57,539	-11.5%	$124,859	0.0%	$2.17	0
2025-Q2	Decreased	65,041	-12.4%	$111,871	0.0%	$1.72	0
2025-Q1	Decreased	74,240	-19.1%	$247,219	0.0%	$3.33	0
2024-Q4	Increased	91,775	+39.5%	$679,135	0.0%	$7.40	32
2024-Q3	Increased	65,779	+34.1%	$617,665	0.0%	$9.39	31
2024-Q2	Decreased	49,061	-21.1%	$393,469	0.0%	$8.02	0
2024-Q1	Increased	62,210	+14.5%	$921,952	0.0%	$14.82	28
2023-Q4	Increased	54,319	+18.1%	$441,614	0.0%	$8.13	28
2023-Q3	Increased	45,994	+10.6%	$209,273	0.0%	$4.55	25
2023-Q2	Increased	41,579	+24.9%	$292,716	0.0%	$7.04	29
2023-Q1	Increased	33,292	+2.6%	$203,414	0.0%	$6.11	23
2022-Q4	Increased	32,456	+8.5%	$207,394	0.0%	$6.39	25
2022-Q3	Increased	29,909	+2.5%	$287,000	0.0%	$9.58	24
2022-Q2	Increased	29,178	+79.6%	$322,000	0.0%	$11.04	36
2022-Q1	Decreased	16,245	-26.5%	$270,000	0.0%	$16.65	0
2021-Q4	Decreased	22,096	-33.3%	$422,000	0.0%	$19.09	0
2021-Q3	Increased	33,120	+20.6%	$817,000	0.0%	$24.66	30
2021-Q2	Increased	27,463	+35.0%	$715,000	0.0%	$26.02	32
2021-Q1	Decreased	20,338	-10.2%	$644,000	0.0%	$31.66	0
2020-Q4	Decreased	22,637	-4.1%	$1.1M	0.0%	$46.40	0
2020-Q3	Increased	23,599	+2.7%	$777,000	0.0%	$32.92	25
2020-Q2	Decreased	22,976	-5.1%	$631,000	0.0%	$27.45	0
2020-Q1	Decreased	24,208	-43.9%	$725,000	0.0%	$29.94	0
2019-Q4	Decreased	43,173	-7.3%	$1.2M	0.0%	$27.68	0
2019-Q3	Decreased	46,583	-1.4%	$848,000	0.0%	$18.20	0
2019-Q2	Decreased	47,266	-11.6%	$1.2M	0.0%	$24.52	0
2019-Q1	Increased	53,438	+1.1%	$508,000	0.0%	$9.51	24
2018-Q4	First report	52,874	-	$468,000	0.0%	$8.85	0

Other major holders of IOVA: ARK Investment Management LLC, Franklin Templeton Inc., Avoro Capital Advisors LLC